Technical Analysis for GBT - Global Blood Therapeutics, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 27.73 | -1.70% | -0.48 |
GBT closed down 1.7 percent on Tuesday, July 27, 2021, on 83 percent of normal volume. The bears made the stock sink to a new 52-week low. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Earnings due: Aug 3
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Historical GBT trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing Low | Bearish | 0.00% | |
| New Downtrend | Bearish | 0.00% | |
| Hammer Candlestick | Bullish | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| New 52 Week Low | Weakness | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| Down 4 Days in a Row | Weakness | 0.00% | |
| Down 5 Days in a Row | Weakness | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| Down 3% | about 13 hours ago |
| Fell Below Lower Bollinger Band | about 13 hours ago |
| Down 2 % | about 13 hours ago |
| Down 1% | about 14 hours ago |
| Fell Below Previous Day's Low | about 14 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 08/03/2021
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics to treat grievous blood-based disorders. Its product candidate is GBT440, a hemoglobin modifier that binds to hemoglobin molecules, which is in double-blind Phase I/II clinical trial indicated for the treatment of sickle cell disease. The company also focuses on developing an oral prophylactic therapy for hypoxemic pulmonary disorders and hereditary angioedema. The company was founded in 2011 and is based in South San Francisco, California.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Hemoglobin Blood Angioedema Hereditary Angioedema Sickle Cell Disease Hemoglobins Pulmonary Disorders
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Hemoglobin Blood Angioedema Hereditary Angioedema Sickle Cell Disease Hemoglobins Pulmonary Disorders
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 71.23 |
| 52 Week Low | 27.1 |
| Average Volume | 1,086,974 |
| 200-Day Moving Average | 43.17 |
| 50-Day Moving Average | 35.73 |
| 20-Day Moving Average | 32.36 |
| 10-Day Moving Average | 30.36 |
| Average True Range | 1.46 |
| ADX | 25.77 |
| +DI | 11.87 |
| -DI | 39.22 |
| Chandelier Exit (Long, 3 ATRs) | 33.22 |
| Chandelier Exit (Short, 3 ATRs) | 31.47 |
| Upper Bollinger Bands | 37.39 |
| Lower Bollinger Band | 27.34 |
| Percent B (%b) | 0.04 |
| BandWidth | 31.04 |
| MACD Line | -2.18 |
| MACD Signal Line | -1.77 |
| MACD Histogram | -0.4113 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 29.29 | ||||
| Resistance 3 (R3) | 29.25 | 28.70 | 29.03 | ||
| Resistance 2 (R2) | 28.70 | 28.30 | 28.72 | 28.94 | |
| Resistance 1 (R1) | 28.21 | 28.05 | 27.94 | 28.25 | 28.86 |
| Pivot Point | 27.66 | 27.66 | 27.52 | 27.68 | 27.66 |
| Support 1 (S1) | 27.17 | 27.26 | 26.90 | 27.21 | 26.60 |
| Support 2 (S2) | 26.62 | 27.01 | 26.64 | 26.52 | |
| Support 3 (S3) | 26.13 | 26.62 | 26.43 | ||
| Support 4 (S4) | 26.17 |
